Hospital Authority of Valdosta and Lowndes County Georgia

Hospital Authority of Valdosta and Lowndes County Georgia was paid $14.01M by Medicaid between Jan 2018 and Dec 2024, across 228 billing codes. Its largest line is 99282, Emergency department visit for the evaluation and management, low to moderate severity — 14% of everything it billed.

Box 24A · Dates of service

Paid by month

Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider

By year, as a table

Year	Claims	Paid
2018	103,833	$2.84M
2019	95,583	$2.58M
2020	50,217	$1.48M
2021	58,462	$1.59M
2022	49,556	$1.59M
2023	51,996	$2.07M
2024incomplete	46,000	$1.86M

Box 24 · Service lines

What it billed for

Code	Service	Share	Claims	Bene. records	Paid
99282	Emergency department visit for the evaluation and management, low to moderate severity	14%	25,732	22,497	$2.03M
99283	Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity	13%	16,206	14,086	$1.78M
99284	Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity	6.8%	6,154	5,624	$957K
74177	Computed tomography, abdomen and pelvis; with contrast material	5.6%	1,411	1,360	$781K
A0429	Emergency ambulance ride, basic life supportAmbulance service, basic life support, emergency transport (bls-emergency)	5.1%	3,354	3,043	$719K
G0378	Hospital observation service, per hour	3.4%	4,579	1,687	$476K
A0427	Emergency ambulance ride, advanced life supportAmbulance service, advanced life support, emergency transport, level 1 (als 1 - emergency)	3.0%	1,650	1,484	$420K
70450	Computed tomography, head or brain; without contrast material	2.7%	1,921	1,823	$378K
59025	Fetal non-stress test	2.6%	5,718	3,906	$362K
99285	Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life	2.5%	1,696	1,575	$356K
96361	Intravenous infusion, hydration; each additional hour	2.1%	5,115	4,016	$300K
87633	Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets	1.8%	3,431	3,304	$256K

216 more codes

87637	Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV	1.5%	4,743	$205K
99213	Doctor's office visit, returning patient (routine)	1.3%	4,416	$188K
99211	Office or other outpatient visit for the evaluation and management of an established patient, minimal severity	1.3%	5,300	$187K
99212	Office or other outpatient visit for the evaluation and management of an established patient, straightforward	1.3%	4,237	$177K
96360	Intravenous infusion, hydration; initial, 31 minutes to 1 hour	1.2%	2,554	$175K
93005	Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report	1.2%	7,823	$171K
85025	Blood count; complete (CBC), automated, and automated differential WBC count	1.2%	28,031	$165K
96374	Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance	1.1%	5,574	$155K
Q9967	Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml	1.0%	2,379	$143K
96365	Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour	<1%	2,124	$135K
96372	Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular	<1%	5,645	$134K
71046	Radiologic examination, chest; 2 views	<1%	2,671	$134K
A0425	Ground mileage, per statute mile	<1%	2,945	$125K
71045	Radiologic examination, chest; single view	<1%	7,268	$124K
99281	Emergency department visit for the evaluation and management, self-limited or minor	<1%	2,063	$109K
80048	Basic metabolic panel (calcium, ionized)	<1%	18,027	$103K
87635	Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe	<1%	3,025	$99K
99214	Doctor's office visit, returning patient (more involved)	<1%	2,010	$98K
94640	Pressurized or nonpressurized inhalation treatment for acute airway obstruction	<1%	2,498	$94K
93306	Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete	<1%	337	$89K
96375	Therapeutic injection; each additional sequential IV push	<1%	3,648	$84K
80053	Comprehensive metabolic panel	<1%	8,182	$80K
87426	Infectious agent antigen detection, SARS-CoV-2 (COVID-19)	<1%	2,322	$73K
87491	Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe	<1%	5,338	$70K
87798	Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism	<1%	3,558	$67K
84443	Thyroid stimulating hormone (TSH)	<1%	4,498	$66K
87804	Infectious agent antigen detection by immunoassay; Influenza, each type	<1%	4,836	$64K
87507		<1%	316	$64K
36415	Collection of venous blood by venipuncture	<1%	32,395	$62K
D9420		<1%	51	$60K
87591	Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe	<1%	5,291	$59K
87428		<1%	1,557	$57K
80307	Drug test(s), presumptive, any number of drug classes; immunoassay	<1%	1,817	$56K
87088		<1%	9,682	$55K
76817	Ultrasound, pregnant uterus, real time with image documentation, transvaginal	<1%	729	$51K
88305	Level IV - Surgical pathology, gross and microscopic examination	<1%	730	$50K
87660		<1%	3,650	$44K
80076		<1%	10,903	$44K
76705	Ultrasound, abdominal, real time with image documentation; limited	<1%	556	$43K
74018		<1%	987	$42K
87480		<1%	3,448	$42K
U0003	Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r	<1%	520	$41K
87581		<1%	3,491	$41K
87510		<1%	3,448	$41K
87486		<1%	3,491	$40K
87506		<1%	461	$40K
81001		<1%	17,513	$37K
84703		<1%	9,897	$36K
87880	Infectious agent antigen detection by immunoassay; Streptococcus, group A	<1%	3,678	$29K
80061	Lipid panel	<1%	2,111	$25K
87631		<1%	550	$25K
86901		<1%	2,088	$23K
82306	Vitamin D; 25 hydroxy, includes fraction(s), if performed	<1%	808	$22K
83690		<1%	6,392	$22K
84484		<1%	4,170	$21K
84702		<1%	4,074	$21K
84439		<1%	2,250	$20K
87077		<1%	2,992	$19K
76815	Ultrasound, pregnant uterus, real time with image documentation, limited	<1%	315	$17K
87651	Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe	<1%	1,607	$17K
83036	Hemoglobin; glycosylated (A1C)	<1%	2,000	$17K
87502	Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets	<1%	612	$16K
99215	Doctor's office visit, returning patient (complex)	<1%	211	$16K
88142		<1%	1,069	$16K
72125	Computed tomography, cervical spine; without contrast material	<1%	97	$15K
82728		<1%	1,137	$15K
87186		<1%	2,216	$15K
96376		<1%	252	$15K
85027		<1%	2,053	$15K
73630		<1%	375	$14K
83735		<1%	2,320	$14K
74176	Computed tomography, abdomen and pelvis; without contrast material	<1%	42	$13K
82607		<1%	957	$13K
95816		<1%	77	$13K
87081		<1%	2,385	$13K
87420		<1%	1,227	$13K
87040		<1%	1,375	$12K
84112		<1%	180	$11K
73130		<1%	352	$11K
J0330	Injection, succinylcholine chloride, up to 20 mg	<1%	376	$10K
80329		<1%	673	$10K
85730		<1%	2,113	$10K
86850		<1%	960	$10K
M0243	Intravenous infusion or subcutaneous injection, casirivimab and imdevimab includes infusion or injection, and post administration monitoring	<1%	44	$8K
71275	Computed tomographic angiography, chest, with contrast material	<1%	29	$8K
86003		<1%	266	$8K
86696		<1%	534	$8K
73610		<1%	314	$8K
85610		<1%	2,415	$8K
86900		<1%	2,089	$8K
87070		<1%	848	$7K
85007		<1%	2,102	$7K
82947		<1%	1,842	$7K
87661	Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe	<1%	466	$7K
87340		<1%	770	$7K
86140		<1%	1,305	$7K
0001A		<1%	227	$6K
83540		<1%	830	$6K
83615		<1%	1,145	$6K
83550		<1%	639	$6K
J2704	Injection, propofol, 10 mg	<1%	2,550	$5K
J1885	Injection, ketorolac tromethamine, per 15 mg	<1%	4,596	$5K
82746		<1%	355	$5K
J3010	Injection, fentanyl citrate, 0.1 mg	<1%	2,453	$5K
96366	Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour	<1%	80	$4K
73560		<1%	126	$4K
87389	Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies	<1%	226	$4K
80320		<1%	626	$4K
86695		<1%	535	$4K
0002A		<1%	117	$4K
J2270	Injection, morphine sulfate, up to 10 mg	<1%	1,257	$4K
82247		<1%	662	$4K
86592		<1%	1,342	$4K
87045		<1%	237	$4K
72082		<1%	41	$4K
J2405	Injection, ondansetron hydrochloride, per 1 mg	<1%	5,846	$4K
J1100	Injection, dexamethasone sodium phosphate, 1 mg	<1%	4,069	$3K
73110		<1%	102	$3K
J0696	Injection, ceftriaxone sodium, per 250 mg	<1%	2,312	$3K
82553		<1%	351	$3K
80069		<1%	336	$3K
82550		<1%	672	$3K
99201		<1%	114	$3K
94770		<1%	80	$3K
72100		<1%	55	$3K
85652		<1%	961	$3K
86703		<1%	501	$3K
76819	Fetal biophysical profile; without non-stress testing	<1%	32	$3K
J1756	Injection, iron sucrose, 1 mg	<1%	59	$3K
J0690	Injection, cefazolin sodium, 500 mg	<1%	1,127	$3K
96413	Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance	<1%	23	$3K
73030		<1%	79	$2K
86762		<1%	268	$2K
82105		<1%	127	$2K
96367		<1%	48	$2K
81003		<1%	1,056	$2K
82785		<1%	95	$2K
84460		<1%	359	$2K
84450		<1%	359	$2K
J2175	Injection, meperidine hydrochloride, per 100 mg	<1%	476	$2K
87653		<1%	93	$2K
99203	Doctor's office visit, new patient (routine)	<1%	40	$2K
77067	Screening mammography, bilateral, including computer-aided detection	<1%	15	$2K
83020		<1%	270	$2K
85378		<1%	358	$2K
73090		<1%	59	$2K
85384		<1%	210	$2K
84478		<1%	318	$2K
84156		<1%	501	$2K
J1170	Injection, hydromorphone, up to 4 mg	<1%	665	$2K
76830	Ultrasound, transvaginal	<1%	42	$2K
Q0162	Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen	<1%	2,874	$2K
84560		<1%	308	$2K
82950		<1%	301	$2K
82465		<1%	328	$2K
83605		<1%	215	$1K
84550		<1%	312	$1K
88304		<1%	61	$1K
10060		<1%	12	$1K
84155		<1%	335	$1K
83021		<1%	270	$1K
86803		<1%	163	$1K
99202	Office or other outpatient visit for the evaluation and management of a new patient, straightforward	<1%	36	$1K
J3105	Injection, terbutaline sulfate, up to 1 mg	<1%	352	$1K
J0702	Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg	<1%	48	$1K
0352U		<1%	314	$1K
82977		<1%	195	$1K
12011		<1%	13	$942.32
J2550	Injection, promethazine hcl, up to 50 mg	<1%	528	$918.59
82784		<1%	54	$913.79
J2765	Injection, metoclopramide hcl, up to 10 mg	<1%	571	$912.32
84100		<1%	254	$903.46
80143		<1%	234	$900.05
82570		<1%	193	$889.85
80179		<1%	229	$883.37
83001		<1%	41	$877.50
83874		<1%	78	$817.67
J2250	Injection, midazolam hydrochloride, per 1 mg	<1%	2,134	$796.75
86738		<1%	47	$747.58
87046		<1%	238	$687.69
85014		<1%	283	$670.99
85018		<1%	261	$649.69
74022		<1%	15	$631.23
83002		<1%	25	$587.10
76641		<1%	13	$578.68
83516		<1%	36	$552.70
87205		<1%	184	$539.57
72081		<1%	14	$512.15
J7510	Prednisolone oral, per 5 mg	<1%	382	$475.90
J1200	Injection, diphenhydramine hcl, up to 50 mg	<1%	783	$471.89
82043		<1%	66	$469.20
86039		<1%	32	$444.45
29105		<1%	12	$419.95
73070		<1%	12	$396.45
J7060	5% dextrose/water (500 ml = 1 unit)	<1%	137	$361.07
87338		<1%	15	$279.06
80354		<1%	82	$266.17
70320		<1%	51	$263.76
0071A		<1%	20	$223.75
83525		<1%	24	$209.17
J1644	Injection, heparin sodium, per 1000 units	<1%	332	$197.27
87177		<1%	15	$158.77
82575		<1%	14	$158.07
87807		<1%	31	$151.83
J7613	Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg	<1%	289	$150.33
93010	Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only	<1%	319	$92.31
82150		<1%	12	$84.02
J7644	Ipratropium bromide, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, per milligram	<1%	28	$78.66
83655		<1%	14	$55.95
J2930	Injection, methylprednisolone sodium succinate, up to 125 mg	<1%	14	$55.64
80345		<1%	13	$40.35
84132		<1%	20	$29.78
S0119	Ondansetron, oral, 4 mg (for circumstances falling under the medicare statute, use hcpcs q code)	<1%	45	$19.27
36416		<1%	49	$9.60
81015		<1%	60	$4.27
J7512	Prednisone, immediate release or delayed release, oral, 1 mg	<1%	15	$2.92

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialHODGES, JULIE (CONTROLLER)

Same official

Other billing entities under HODGES, JULIE

Full network →

Provider	Location	Paid
SGMC Physician Network INC	Valdosta, GA	$0.00

Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.